Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV

NCT04431375 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Acute-On-Chronic Liver Failure
Hepatitis B

Interventions

BIOLOGICAL: Plasma Exchange
DRUG: Tenofovir
OTHER: Fecal Mircobiota Transplantation

Sponsor

Institute of Liver and Biliary Sciences, India